Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-na\uefve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
- Publication date
- 1 January 2020
- Publisher
- Blackwell Publishing Ltd